Scientists test MRI reliability for tracking brain tumors
NCT ID NCT06648473
Summary
This study aimed to see how consistently MRI scans could measure changes in a specific type of slow-growing brain tumor (low-grade glioma) in patients taking the drug ivosidenib. It planned to enroll 40 adults who were already scheduled for a routine MRI as part of their care. The goal was to create a reliable dataset to help improve future software for tracking tumor size, but the study was withdrawn before any participants were enrolled.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for LOW GRADE GLIOMA OF BRAIN are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Duke University Medical Center
Durham, North Carolina, 27710, United States
Conditions
Explore the condition pages connected to this study.